The microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties

Published:2009-01-10 Issue:4 Volume:64 Page:681-689
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Beyer Carl F.,Zhang Nan,Hernandez Richard,Vitale Danielle,Nguyen Thai,Ayral-Kaloustian Semiramis,Gibbons James J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-008-0916-2.pdf

Reference25 articles.

1. Zhang N, Ayral-Kaloustian S, Nguyen T, Afragola J, Hernandez R, Lucas J et al (2007) Synthesis and SAR of [1, 2, 4]triazolo[1, 5-a]pyrimidines, a class of anticancer agents with a unique mechanism of tubulin inhibition. J Med Chem 50:319–327

2. Beyer CF, Zhang N, Hernandez R, Vitale D, Lucas J, Nguyen T et al (2008) TTI-237: a novel microtubule-active compound with in vivo antitumor activity. Cancer Res 68:2292–2300

3. Hamel E (1996) Antimitotic natural products and their interactions with tubulin. Med Res Rev 16:207–231

4. Krutzik PO, Nolan GP (2003) Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry Part A 55A:61–70

5. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud O, Gjertsen BT et al (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118:217–228

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Creation of a Chiral All-Carbon Quaternary Center Induced by CF₃ and CH₃ Substituents via Cu-Catalyzed Asymmetric Conjugate Addition;Organic Letters;2024-06-13

2. Cevipabulin induced abnormal tubulin protofilaments polymerization by binding to Vinblastine site and The Seventh site;Cytoskeleton;2023-12-05

3. Recent Progress on Microtubule Degradation Agents;Journal of Medicinal Chemistry;2023-09-25

4. Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells;Bioorganic Chemistry;2023-09

5. Triazole-fused pyrimidines in target-based anticancer drug discovery;European Journal of Medicinal Chemistry;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3